The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death worldwide. Liver cancer is generally related to hepatitis B or C infection and cirrhosis. Usually, patients with HCC are asymptomatic and are diagnosed at late stages when surgical treatment is no longer suitable. Limited treatment options for patients with advanced HCC are a major concern. Therefore, there is an urge for finding novel therapies to treat HCC. Liver cancer is highly heterogeneous and involved deregulation of several signaling pathways. Wnt/β-catenin pathway is frequently upregulated in HCC and it is implicated in maintenance of tumor initiating cells, drug resistance, tumor progression, and metastasis. A great effort in developing selective drugs to target components of the β-catenin pathway with anticancer activity is underway but only a few of them have reached phase I clinical trials. We aim to review the role of β-catenin pathway on hepatocarcinogenesis and liver cancer stem cell maintenance. We also evaluated the use of small molecules targeting the Wnt/β-catenin pathway with potential application for treatment of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D., Wilhelm, S., Lynch, M., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,536
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Functional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260
Association of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223
Association of the APC Tumor Suppressor Protein with Catenins
Su, L.-K., Vogelstein, B., & Kinzler, K. W. (1993) · Science · doi:10.1126/science.8259519 · Cited by 1,188
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation
Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., & He, X. (2005) · Nature · doi:10.1038/nature04185 · Cited by 849
Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., & Polakis, P. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70226-x · Cited by 836
MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
Ji, J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S., Ambs, S., Chen, Y., Meltzer, P. S., Croce, C. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901282 · Cited by 802
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614
Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Takahashi-Yanaga, F., & Kahn, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2943 · Cited by 499
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
Taniguchi, K., Roberts, L. R., Aderca, I. N., Dong, X., Qian, C., Murphy, L. M., Nagorney, D. M., Burgart, L. J., Roche, P. C., Smith, D. I., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205591 · Cited by 486
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485
Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma
Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0908 · Cited by 446
Dysregulation of growth factor signaling in human hepatocellular carcinoma
Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 391
Wong, C. M., Fan, S. T., & Ng, I. O. L. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1<136::aid-cncr1301>3.0.co;2-r · Cited by 348
Waaler, J., Machon, O., Tumova, L., Dinh, H., Korinek, V., Wilson, S. R., Paulsen, J. E., Pedersen, N. M., Eide, T. J., Machonova, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3336 · Cited by 328
Genetics of hepatocellular tumors
Laurent-Puig, P., & Zucman-Rossi, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209547 · Cited by 317
Lachenmayer, A., Alsinet, C., Savic, R., Cabellos, L., Toffanin, S., Hoshida, Y., Villanueva, A., Minguez, B., Newell, P., Tsai, H.-W., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2322 · Cited by 306
Apoptotic Effects of Chrysin in Human Cancer Cell Lines
Khoo, B. Y., Chua, S. L., & Balaram, P. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11052188 · Cited by 304
Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., & Buendia, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65168-1 · Cited by 295
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad
Nejak-Bowen, K. N., & Monga, S. P. S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.010 · Cited by 260
The links between axin and carcinogenesis
Salahshor, S., & Woodgett, J. R. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.009506 · Cited by 249
Song, W., Li, H., Tao, K., Li, R., Song, Z., Zhao, Q., Zhang, F., & Dou, K. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01777.x · Cited by 226
Newell, P., Toffanin, S., Villanueva, A., Chiang, D. Y., Minguez, B., Cabellos, L., Savic, R., Hoshida, Y., Lim, K. H., Melgar-Lesmes, P., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.028 · Cited by 222
Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Sukhdeo, K., Mani, M., Zhang, Y., Dutta, J., Yasui, H., Rooney, M. D., Carrasco, D. E., Zheng, M., He, H., Tai, Y.-T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610299104 · Cited by 216
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
Bengochea, A., de Souza, M. M., Lefrançois, L., Le Roux, E., Galy, O., Chemin, I., Kim, M., Wands, J. R., Trepo, C., Hainaut, P., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604422 · Cited by 215
Xu, J., Zhu, X., Wu, L., Yang, R., Yang, Z., Wang, Q., & Wu, F. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02750.x · Cited by 215
Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
Ji, J., & Wang, X. W. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.011 · Cited by 210
Inagawa, S., Itabashi, M., Adachi, S., Kawamoto, T., Hori, M., Shimazaki, J., Yoshimi, F., & Fukao, K. (2002) · PubMed · Cited by 196
Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations
Harada, N., Oshima, H., Katoh, M., Tamai, Y., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2123 · Cited by 194
A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities
Handeli, S., & Simon, J. A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2063 · Cited by 183
Unique phenotype of hepatocellular cancers with exon‐3 mutations in beta‐catenin gene†
Cieply, B., Zeng, G., Proverbs‐Singh, T., Geller, D. A., & Monga, S. P. S. (2009) · Hepatology · doi:10.1002/hep.22695 · Cited by 174
Molecular Biology of Liver Cancer Stem Cells
Oishi, N., Yamashita, T., & Kaneko, S. (2014) · Liver Cancer · doi:10.1159/000343863 · Cited by 169
Wnt/frizzled signaling in hepatocellular carcinoma
Lee, H. C., Kim, M., & Wands (2006) · Frontiers in bioscience · doi:10.2741/1933 · Cited by 164
Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Bao, R., Christova, T., Song, S., Angers, S., Yan, X., & Attisano, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048670 · Cited by 161
MicroRNA signatures in liver diseases
Chen, X. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1665 · Cited by 158
Axin prevents Wnt-3a-induced accumulation of β-catenin
Kishida, M., Koyama, S., Kishida, S., Matsubara, K., Nakashima, S., Higano, K., Takada, R., Takada, S., & Kikuchi, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202388 · Cited by 153
Wei, W., Chua, M., Grepper, S., & So, S. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.24810 · Cited by 146
Gedaly, R., Angulo, P., Hundley, J. C., Daily, M. F., Chen, C., Koch, A., & Evers, B. M. (2010) · PubMed · Cited by 143
Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma
Ji, J., Yamashita, T., & Wang, X. W. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-4 · Cited by 137
Gandhirajan, R. K., Staib, P., Minke, K., Gehrke, I., Plickert, G., Schlösser, A., Schmitt, E. K., Hallek, M. J., & Kreuzer, K. (2010) · Neoplasia · doi:10.1593/neo.91972 · Cited by 134
The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers
Hou, Y., Zou, Q., Ge, R., Shen, F., & Wang, Y. (2011) · Cell Research · doi:10.1038/cr.2011.139 · Cited by 128
Tian, X., Hou, W., Fang, Y., Fan, J., Tong, H., Bai, S., Qu, C., Xu, H. J., & Li, Y. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-100 · Cited by 125
Gedaly, R., Galuppo, R., Daily, M. F., Shah, M. B., Maynard, E. C., Chen, C., Zhang, X., Esser, K. A., Cohen, D. A., Evers, B. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099272 · Cited by 121
Ma, L., Wang, X., Jia, T., Wei, W., Chua, M., & So, S. K. (2015) · Oncotarget · doi:10.18632/oncotarget.4455 · Cited by 106
Wnt/β-Catenin Pathway in Hepatocellular Carcinoma Pathogenesis and Liver Physiology
Cavard, C., Colnot, S., Audard, V., Benhamouche, S., Finzi, L., Torre, C., Grimber, G., Godard, C., Terris, B., & Perret, C. (2008) · Future Oncology · doi:10.2217/14796694.4.5.647 · Cited by 102
Wei, W., Chua, M., Grepper, S., & So, S. K. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-16 · Cited by 101
Augello, C., Vaira, V., Caruso, L., Destro, A., Maggioni, M., Park, Y. N., Montorsi, M., Santambrogio, R., Roncalli, M. G., & Bòsari, S. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02795.x · Cited by 97
QU, B., LIU, B.-R., DU, Y.-J., CHEN, J., CHENG, Y.-Q., XU, W., & WANG, X.-H. (2014) · Oncology Letters · doi:10.3892/ol.2014.1828 · Cited by 96
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma
Nambotin, S. B., Lefrançois, L., Sainsily, X., Berthillon, P., Kim, M., Wands, J. R., Chevallier, M., Jalinot, P., Scoazec, J., TREPO, C. G., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.033 · Cited by 92
Minke, K., Staib, P., Puetter, A., Gehrke, I., Gandhirajan, R. K., Schlösser, A., Schmitt, E. K., Hallek, M. J., & Kreuzer, K. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01188.x · Cited by 90
Evidence for tankyrases as antineoplastic targets in lung cancer
Busch, A. M., Johnson, K. C., Stan, R. V., Sanglikar, A., Ahmed, Y. F., Dmitrovsky, E., & Freemantle, S. J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-211 · Cited by 88
Galuppo, R., Maynard, E. C., Shah, M. B., Daily, M. F., Chen, C., Spear, B. T., & Gedaly, R. (2014) · PubMed · Cited by 86
Liu, G., Jiang, S., Wang, C., Jiang, W., Liu, Z., Liu, C., Saiyin, H., Yang, X., Shen, S., Jiang, D., et al. (2011) · Hepatology · doi:10.1002/hep.25564 · Cited by 62
Identification and Characterization of a Novel Small-Molecule Inhibitor of β-Catenin Signaling
Delgado, E. R., Yang, J., So, J., Fanti, M., Leimgruber, S., Kahn, M., Ishitani, T., Shin, D., Wilson, G. M., & Monga, S. P. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.04.002 · Cited by 39
Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice
Kudo, M. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-010-0089-y · Cited by 32
LIU, J., Li, G., Liu, D., & Liu, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1928 · Cited by 16
Wang, B., XunSun, Liu, J.-Y., Yang, D., Yang, L., Kong, D.-X., & Meng, X. (2011) · Hepatogastroenterology · doi:10.5754/hge11534 · Cited by 16
Kril, L. M., Vilchez, V., Jiang, J., Turcios, L. M., Chen, C., Sviripa, V. M., Zhang, W., Liu, C., Spear, B. T., Watt, D. S., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.040 · Cited by 15
Self-citation
Cited by
Evolving therapeutic landscape of advanced hepatocellular carcinoma
Yang, C., Zhang, H., Zhang, L., Zhu, A. X., Bernards, R., Qin, W., & Wang, C. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00704-9 · Cited by 727
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
Shang, S., Hua, F., & Hu, Z.-W. (2017) · Oncotarget · doi:10.18632/oncotarget.15687 · Cited by 641
β-Catenin signaling in hepatocellular carcinoma
Xu, C., Xu, Z., Zhang, Y., Evert, M., Calvisi, D. F., & Chen, X. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154515 · Cited by 305
Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma
Chen, B., Garmire, L., Calvisi, D. F., Chua, M.-S., Kelley, R. K., & Chen, X. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0240-9 · Cited by 154
Cell signaling and cancer: a mechanistic insight into drug resistance
Panda, M., & Biswal, B. K. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04958-6 · Cited by 89
Metadata
- Authors
- Vilchez, V.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 22
- Issue
- 2
- Pages
- 823
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2419193153
- Cited by
- 312
- References
- 74
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.